Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: July 25, 2024
Reporting Period Context: This filing announces an upcoming conference call to discuss financial results for the quarter ended June 30, 2024, and provide a corporate update.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notification of an upcoming earnings announcement.
Material Changes
No material financial changes or operational updates are detailed within this specific filing. The document references a press release (Exhibit 99.1) containing the announcement but does not include the financial data itself.
Guidance, Outlook, and Management Commentary
- Upcoming Event: A conference call is scheduled for Thursday, August 1, 2024, at 4:30 p.m. Eastern Time.
- Discussion Topics: Results for the quarter ended June 30, 2024, and a corporate update.
- Emerging Growth Company Status: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for preliminary details.
- Confirm the date and time of the earnings conference call (August 1, 2024, 4:30 p.m. ET).
- Review the subsequent Form 10-Q filing for the quarter ended June 30, 2024, to obtain actual financial metrics.
- Check for any updates to the company's emerging growth company status or election regarding extended transition periods.